OICR Genomics

Our first @illumina NovaSeq X Plus has passed all our QCs and is now fully operational! Effective immediately, prices for our Core Assays are cut by >30% for new projects (see genomics.oicr.on.ca). What Core Assays you ask? /1 of 7

We are excited to share that @OICRGenomics has launched services on the @UltimaGenomics UG100 sequencing platform, the first of these state-of-the-art machines in Canada! Read more about this significant upgrade to Ontario's cancer research infrastructure: bit.ly/42KQKXe

@UltimaGenomics @OICR_news A huge thank you to the @UltimaGenomics team for making this milestone a reality. We’re excited to embark on this partnership and shape the future of genomics together.

We’re delighted to introduce the @UltimaGenomics UG100 high-throughput sequencer, a groundbreaking addition to our state-of-the-art genomics arsenal at @OICR_news #Genomics. Stay tuned for our official launch date!! #CancerResearch

#NouveauDansLeNav - Programme de génomique de l’Institut ontarien de recherche sur le cancer Offre des services cliniques et des services de #RechercheGénomique, spécialisé dans le séquençage du génome et du transcriptome entiers. 👉 bit.ly/3v9aJjK @OICRGenomics

#NewOnTheNav - OICR Genomics, Ontario Institute for Cancer Research @OICRGenomics is an accredited laboratory that offers clinical and research genomics services, specializing in whole genome and transcriptome sequencing. Learn more 👉 bit.ly/3v2rEoj #GenomicsResearch

Read this week's cancer research news roundup, featuring news on @LHSCCanada, @OICRGenomics and more! mailchi.mp/oicr/news-roun… #cancerresearch #pancreaticcacner #clinicaltrials #genomics #cervicalcancer #immunotherapy #AI #lungcancer

.@OICRGenomics and their collaborators @pmcancercentre are using the latest technology to deliver crucial genomic information for patients in clinical trials and to help develop the next generation of precision treatments for cancer. youtu.be/DLYPX5C4db4?si… @illumina

The wait is over. Take your projects to the next level with 52 billion paired-end reads and 8Tb of output. Learn more about the speed, scale, and power of the 25B flow cell on the #NovaSeqX: bit.ly/3MrKZFd

Read the powerful story behind #research into a new blood test for #cancer through the eyes of a mother & daughter with a hereditary condition that comes with near 100% risk of cancer Story▶️thestar.com/news/canada/th… Research▶️@pmcancercentre @SickKidsNews @OICRGenomics @PughLab

Researchers from @UHN @SickKidsNews & @OICR_news have found that analyzing patients' blood samples can detect cancer earlier in individuals with Li-Fraumeni syndrome, an inherited condition with a near 100% lifetime risk of developing cancer. Read more → bit.ly/3tIWEcr

How can a blood test developed by @OICRGenomics help find #cancer earlier and change the lives of people who inherit a high risk of cancer? ▶️oicr.on.ca/landmark-study… Dr. Trevor Pugh (@PughLab) explains his new landmark study with colleagues @pmcancercentre @UHN @SickKidsNews

The first Collaborative Research Resources info session is tomorrow at 3 p.m. We hope that you will join us to learn how you can access OICR's unique capabilities and technologies. This session will cover @OICRGenomics, @ON_HealthStudy, and more! oicr.on.ca/events/collabo…

Join us on Sept. 27 for our Molecular Diagnostics Open House to learn about how to access OICR's services and technologies to advance your research projects. In-person spaces are limited, so register today! oicr.on.ca/events/oicr-mo…

Enjoyed giving my talk at #CGC2023: "Djerba: A modular system to generate clinical genome interpretation reports for cancer" Slides: github.com/oicr-gsi/djerb… Sign up for early access: github.com/oicr-gsi/djerb… #cancer #genomics @OICR_news @OICRGenomics @CG_Consortium

Don't miss TWO oral presentations from our team at @CG_Consortium in St Louis this week! 1) Sun 2:15pm #FelixBeaudry validation of cfDNA WGS for pan-cancer MRD (see prev post). 2) Mon 8am @IainBancarz Djerba, our open source clinical WGTS/cfDNA reporting software #CGCAnnual2023

@OmicsOmicsBlog Open source! We helped develop and continue to maintain MISO LIMS: miso-lims.readthedocs.io/projects/docs/… and github.com/miso-lims/miso… Given an uptick in inquiries, we are considering offering a paid service for setup and ongoing maintenance of MISO instances. DM us if interested!

In the clinical NGS world, what do people use for LIMS/ELN? Is it pretty much everyone builds their own, or are there commercial systems out there with decent market penetration?

Another huge achievement that will advance research into #precisionmedicine strategies for #cancer that are easier on patients Congrats to the @OICRGenomics team! oicr.on.ca/oicr-introduce…

Prices and protocols (See 30X Plasma WGS): genomics.oicr.on.ca/services Background science: nature.com/articles/s4159… @OICR_news : oicr.on.ca/oicr-introduce…

Plasma WGS for MRD now validated under CAP/CLIA/ACDx: 30X blood cfDNA to detect minimal residual disease using mutational sampling (as pioneered by @landau_lab). This blood test works for any cancer with >4k mutations (most have ~10k). Pairs beautifully with our WGTS tumour test!

And then there were two… Lots of @illumina NovaSeq X Plus capacity now for genomes, cell-free DNA, methylation, and more. Come work with us! Updated service menu and pricing at genomics.oicr.on.ca/services